InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Biobillionair post# 28999

Sunday, 06/08/2014 6:49:17 PM

Sunday, June 08, 2014 6:49:17 PM

Post# of 426566
ziploc 1,

Nice thought, however it's 'for profit' company and Vascepa is already the cheapest within category (including OTC products - if you calculate the same EPA dosage)

BB,
Done.

Dear FDA,

As FDA is responsible for protecting the public health by assuring the safety, effectiveness, quality, and security of human drugs, vaccines and other biological products, and medical devices and since more than 1 drug are approved for treatment of very high trglycerides and Vascepa's safety profile is significantly better than

- Lovaza / "generic" Lovaza Omega 3 EE
- Omtryg
- Epanova
(together DHA drugs)

since these drugs increase LDL-C and Atrial Fibrillation rate

FDA has to give CLEAR guidance to the public and to the doctors. The most effective way of this
- to show warnings for DHA drugs in Black Box on their label and package
- issue a DHCP letter
- do not approve any drug with the same side effect (increase LDL-C and / or Atrial Fibrillation rate)

KInd regards,
Gábor Horváth Dori

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News